Tunable rare-earth fcu-metal-organic frameworks

US9920076B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9920076-B2
Application numberUS-201514919238-A
CountryUS
Kind codeB2
Filing dateOct 21, 2015
Priority dateSep 5, 2013
Publication dateMar 20, 2018
Grant dateMar 20, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Metal organic framework compositions can have a face centered cubic structure.

First claim

Opening claim text (preview).

What is claimed is: 1. A metal-organic framework composition, comprising: one or more of a hexanuclear metal cluster, each hexanuclear metal cluster comprising one or more of a rare earth metal ion; and one or more of a bidentate ligand. 2. The composition of claim 1 , wherein the hexanuclear metal cluster is characterized by the formula [RE 6 (μ 3 -OH) 8 (O 2 C—) 6 N 4 C—) 6 ]. 3. The composition of claim 1 , wherein the hexanuclear metal cluster is characterized by the formula [RE 6 (μ 3 -OH) 8 (O 2 C—) 12 ]. 4. The composition of claim 1 , wherein the rare earth metal ion comprises one or more of cerium, dysprosium, erbium, europium, gadolinium, holmium, lanthanum, lutetium, neodymium, praseodymium, promethium, samarium, scandium, terbium, thulium, ytterbium, or yttrium. 5. The composition of claim 1 , wherein the bidentate ligand includes one or more of a carboxylate, tetrazolate, triazolate, or pyrazolate. 6. The composition of claim 1 , wherein the bidentate ligand comprises one or more of the following ligands: 2-fluoro-4-(1H-tetrazol-5-yl)benzoate (FTZB), 4-(1H-tetrazol-5-yl)benzoate (TZB), 3-fluoro-4′-(2H-tetrazol-5-yl)biphenyl-4-carboxylate (FTZBP), 3-fluorobiphenyl-4,4′-dicarboxylate (FBPDC), or 3,3′-difluorobiphenyl-4,4′-dicarboxylate (DFBPDC). 7. The composition of claim 1 , wherein the bidentate ligand has two anionic binding groups. 8. The composition of claim 7 , wherein the two anionic binding groups are the same. 9. The composition of claim 7 , wherein the two anionic binding groups are different. 10. The composition of claim 7 , wherein the two anionic binding groups are linked by one or more of an aromatic group or hydrophobic group. 11. The composition of claim 1 , wherein the hexanuclear metal cluster and bidentate ligand associate to form a face-centered cubic topology. 12. A method of making a metal-organic framework, comprising: contacting one or more of a hexanuclear metal cluster, each hexanuclear metal cluster comprising one or more of a rare earth metal ion, with one or more of a bidentate ligand. 13. The method of claim 12 , wherein the hexanuclear cluster is characterized by the formula [RE 6 (μ 3 -OH) 8 (O 2 C—) 6 N 4 C—) 6 ]. 14. The method of claim 12 , wherein the hexnuclear metal cluster is characterized by the formula [RE 6 (μ 3 -OH) 8 (O 2 C—) 12 ]. 15. The method of claim 12 , wherein the rare earth metal ion includes one or more of cerium, dysprosium, erbium, europium, gadolinium, holmium, lanthanum, lutetium, neodymium, praseodymium, promethium, samarium, scandium, terbium, thulium, ytterbium, or yttrium. 16. The method of claim 12 , wherein the bidentate ligand includes one or more of a carboxylate, tetrazolate, triazolate, or pyrazolate. 17. The method of claim 12 , wherein the bidentate ligand comprises one or more of the following ligands: 2-fluoro-4-(1H-tetrazol-5-yl)benzoate (FTZB), 4-(1H-tetrazol-5-yl)benzoate (TZB), 3-fluoro-4′-(2H-tetrazol-5-yl)biphenyl-4-carboxylate (FTZBP), 3-fluorobiphenyl-4,4′-dicarboxylate (FBPDC), or 3,3′-difluorobiphenyl-4,4′-dicarboxylate (DFBPDC). 18. The method of claim 12 , wherein the bidentate ligand has two anionic binding groups. 19. The method of claim 18 , wherein the two anionic binding groups are linked by one or more of an aromatic group or hydrophobic group. 20. The method of claim 13 , wherein the hexanuclear metal cluster and bidentate ligand associate to form a face-centered cubic topology.

Assignees

Inventors

Classifications

  • C07F5/00Primary

    Compounds containing elements of Groups 3 or 13 of the Periodic Table · CPC title

  • Coordination polymers, e.g. metal-organic frameworks [MOF], zeolitic imidazolate frameworks [ZIF] (preparation of metal complexes containing carboxylic acid moieties C07C51/418; MOF's per se C07F) · CPC title

  • Preparation of metal complexes containing carboxylic acid moieties · CPC title

  • Coordination polymers, e.g. metal-organic frameworks [MOF] (preparation of metal complexes containing carboxylic acid moieties C07C51/418; MOF's per se C07F) · CPC title

  • of CO2 · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9920076B2 cover?
Metal organic framework compositions can have a face centered cubic structure.
Who is the assignee on this patent?
Univ King Abdullah Sci & Tech
What technology area does this patent fall under?
Primary CPC classification C07F5/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).